Cargando…

Natural and Synthetic Anticancer Epidrugs Targeting the Epigenetic Integrator UHRF1

Cancer is one of the leading causes of death worldwide, and its incidence and mortality are increasing each year. Improved therapeutic strategies against cancer have progressed, but remain insufficient to invert this trend. Along with several other risk factors, abnormal genetic and epigenetic regul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ashraf, Waseem, Ahmad, Tanveer, Reynoird, Nicolas, Hamiche, Ali, Mély, Yves, Bronner, Christian, Mousli, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459542/ https://www.ncbi.nlm.nih.gov/pubmed/37630248 http://dx.doi.org/10.3390/molecules28165997

Ejemplares similares

Interaction of the epigenetic integrator UHRF1 with the MYST domain of TIP60 inside the cell
por: Ashraf, Waseem, et al.
Publicado: (2017)

The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer
por: Ashraf, Waseem, et al.
Publicado: (2017)

TIP60 governs the auto-ubiquitination of UHRF1 through USP7 dissociation from the UHRF1/USP7 complex
por: Ahmad, Tanveer, et al.
Publicado: (2021)

Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex
por: Abdullah, Omeima, et al.
Publicado: (2021)

Coordinated Dialogue between UHRF1 and DNMT1 to Ensure Faithful Inheritance of Methylated DNA Patterns
por: Bronner, Christian, et al.
Publicado: (2019)

Thymoquinone challenges UHRF1 to commit auto-ubiquitination: a key event for apoptosis induction in cancer cells
por: Ibrahim, Abdulkhaleg, et al.
Publicado: (2018)

Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties
por: Alhosin, Mahmoud, et al.
Publicado: (2011)

Epigenetic Regulation in Breast Cancer: Insights on Epidrugs
por: Kim, Ayoung, et al.
Publicado: (2023)

Limoniastrum guyonianum aqueous gall extract induces apoptosis in human cervical cancer cells involving p16(INK4A) re-expression related to UHRF1 and DNMT1 down-regulation
por: Krifa, Mounira, et al.
Publicado: (2013)

Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy
por: Choudhry, Hani, et al.
Publicado: (2018)

Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer
por: Alhosin, Mahmoud, et al.
Publicado: (2016)

The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions
por: Bouyahya, Abdelhakim, et al.
Publicado: (2022)

Epidrugs: novel epigenetic regulators that open a new window for targeting osteoblast differentiation
por: Ghorbaninejad, Mahsa, et al.
Publicado: (2020)

Targeting Epigenetic Regulatory Enzymes for Cancer Therapeutics: Novel Small-Molecule Epidrug Development
por: Jin, Ye, et al.
Publicado: (2022)

Epidrugs: Toward Understanding and Treating Diverse Diseases
por: Umehara, Takashi
Publicado: (2022)

The UHRF protein family in epigenetics, development, and carcinogenesis
por: UNOKI, Motoko, et al.
Publicado: (2022)

Phytochemicals as Potential Epidrugs in Type 2 Diabetes Mellitus
por: Ramírez-Alarcón, Karina, et al.
Publicado: (2021)

miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach
por: Salvatori, Francesca, et al.
Publicado: (2023)

Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy
por: Montalvo-Casimiro, Michel, et al.
Publicado: (2020)

Epidrugs in the Therapy of Central Nervous System Disorders: A Way to Drive on?
por: Gladkova, Marina G., et al.
Publicado: (2023)

Epigenetic mechanism and target therapy of UHRF1 protein complex in malignancies
por: Xue, Busheng, et al.
Publicado: (2019)

Novel role of UHRF1 in the epigenetic repression of the latent HIV-1
por: Verdikt, Roxane, et al.
Publicado: (2022)

HISTome2: a database of histone proteins, modifiers for multiple organisms and epidrugs
por: Shah, Sanket G., et al.
Publicado: (2020)

Usefulness of Melatonin and Other Compounds as Antioxidants and Epidrugs in the Treatment of Head and Neck Cancer
por: Guerra, Joaquín, et al.
Publicado: (2021)

Epidrugs as Promising Tools to Eliminate Plasmodium falciparum Artemisinin-Resistant and Quiescent Parasites
por: Reyser, Thibaud, et al.
Publicado: (2023)

Anticancer Activity of Natural and Synthetic Chalcones
por: Constantinescu, Teodora, et al.
Publicado: (2021)

Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs
por: Rath, Suvasmita, et al.
Publicado: (2021)

The multi-functionality of UHRF1: epigenome maintenance and preservation of genome integrity
por: Mancini, Monica, et al.
Publicado: (2021)

Synthetic Advances in Macrosphelides: Natural Anticancer Agents
por: Paek, Seung-Mann
Publicado: (2014)

Cooperative DNA and histone binding by Uhrf2 links the two major repressive epigenetic pathways
por: Pichler, Garwin, et al.
Publicado: (2011)

UHRF1 depletion and HDAC inhibition reactivate epigenetically silenced genes in colorectal cancer cells
por: Niinuma, Takeshi, et al.
Publicado: (2019)

Epidrug-induced upregulation of functional somatostatin type 2 receptors in human pancreatic neuroendocrine tumor cells
por: Veenstra, Marije J., et al.
Publicado: (2016)

Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial
por: de Guillebon, E., et al.
Publicado: (2021)

Acetyltransferase p300 Is a Putative Epidrug Target for Amelioration of Cellular Aging-Related Cardiovascular Disease
por: Ghosh, Asish K.
Publicado: (2021)

Upregulated UHRF1 Promotes Bladder Cancer Cell Invasion by Epigenetic Silencing of KiSS1
por: Zhang, Yu, et al.
Publicado: (2014)

The DNMT1/PCNA/UHRF1 disruption induces tumorigenesis characterized by similar genetic and epigenetic signatures
por: Pacaud, Romain, et al.
Publicado: (2014)

Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression
por: Benavente, Claudia A., et al.
Publicado: (2014)

Epigenetic regulator UHRF1 orchestrates proinflammatory gene expression in rheumatoid arthritis in a suppressive manner
por: Saeki, Noritaka, et al.
Publicado: (2022)

UHRF1 inhibition epigenetically reprograms cancer stem cells to suppress the tumorigenic phenotype of hepatocellular carcinoma
por: Wang, Yanchen, et al.
Publicado: (2023)

Two Important Anticancer Mechanisms of Natural and Synthetic Chalcones
por: Constantinescu, Teodora, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pfbecccbbde82erd1p1126frkl